Medicines

African Drug Regulatory Authorities Conference

Venue

4-6 December 2013
Birchwood Hotel,
Johannesburg South Africa,

The World Health Organization (Headquarters) and WHO Regional Office for Africa will Jointly co-host the Third African Drug Regulatory Authorities Conference, in collaboration with NEPAD Agency. While the first two African Medicines Regulatory Authorities Conferences brought together regulators from sub-Saharan Africa, the third conference is intended to bring together regulators from the whole African continent. The conference will review the medical products (medicines, vaccines, diagnostics and medical devices) regulatory situation in various economic settings, progress made since the Second Conference, identify problems and propose solutions for improving the situation, taking into account current global and regional contexts.

This Conference will bring together representatives from National Medicines Regulatory Authorities, other national stakeholders in medical products regulation (such as associations of manufacturers, traders, consumers, health professionals, researchers, law enforcement officers including the police, customs, the judiciary), civil society, regional and international organizations such as Interpol, Regional Economic Communities and multilateral development partners.

The Conference will be preceded by the 1st Biennial Scientific Conference on Medicines Regulation in Africa, which will take place from 2 to 3 December 2013, at the same venue. The theme of the scientific conference is “Building Partnerships for Sustainable Capacity Development in Medicines Regulation in Africa”.
This Scientific Conference is organized by NEPAD Agency in collaboration with WHO. Full programme of the Scientific Conference is available at: www.amrh.org

For more information please contact:

  • Dr Lembit RÄGO, Head of Regulation of Medicines and Other Health Technologies, WHO HQ, at ragol@who.int,
  • Dr Ossy MJ KASILO, Programme Area Coordinator, Essential Medicines and Health Technologies, WHO-AFRO, at kasiloo@who.int and
  • Dr Marthe EVERARD, Coordinator, Essential Medicines & Pharmaceutical Policies, WHO-EMRO, at everardm@who.int.
Share